| Dr Amber Jackson, DO | |
|
300 E 6th St, Texarkana, AR 71854-5207 | |
| (870) 779-6000 | |
| Not Available |
| Full Name | Dr Amber Jackson |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 4 Years |
| Location | 300 E 6th St, Texarkana, Arkansas |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770105967 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | E-15325 (Arkansas) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Thomas Hospital | Fairhope, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Correct Care, Inc. | 8628980992 | 68 |
| Imc-hospitalists Llc | 2264727155 | 66 |
| Correct Care, Inc. | 8628980992 | 68 |
News Archive
The Clinical and Translational Science Award (CTSA) hub partnership between Virginia Tech, the University of Virginia, Carilion Clinic, and Inova Health System has awarded $200,000 in funding to five research projects through the Pilot Translational and Clinical Studies Program. Multi-institutional teams of scientists, physicians, and engineers will study Parkinson's disease, celiac disease, pediatric heart transplant, pediatric telemedicine, and epilepsy.
From the left, fears persist that this independent payment advisory board will make the Medicare program a cost-control scapegoat. On the right, opponents say the panel will lead to health care rationing and usurp congressional authority.
Microbix Biosystems Inc., a biotechnology company focused on virology and biological technologies, and Therapure Biopharma Inc., an integrated biopharmaceutical company that develops, manufactures, purifies and packages therapeutic proteins, announced today the signing of a partnership agreement to manufacture and market water-based products to the pharmaceutical, biotechnology and other industries.
Intratumor morphological heterogeneity (diversity) of breast cancer is not related to chromosome aberrations. This conclusion was made based on the study of one case with aggressive variant of breast cancer - invasive micropapillary carcinoma by researchers from Tomsk State University, Tomsk Cancer Research Institute, and Institute of Medical Genetics.
The authors of a head-to-head study say that surgery should be considered as a first-line option for women with stress urinary incontinence, ahead of physiotherapy.
› Verified 5 days ago
| Entity Name | Correct Care, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215987441 PECOS PAC ID: 8628980992 Enrollment ID: O20041207001183 |
News Archive
The Clinical and Translational Science Award (CTSA) hub partnership between Virginia Tech, the University of Virginia, Carilion Clinic, and Inova Health System has awarded $200,000 in funding to five research projects through the Pilot Translational and Clinical Studies Program. Multi-institutional teams of scientists, physicians, and engineers will study Parkinson's disease, celiac disease, pediatric heart transplant, pediatric telemedicine, and epilepsy.
From the left, fears persist that this independent payment advisory board will make the Medicare program a cost-control scapegoat. On the right, opponents say the panel will lead to health care rationing and usurp congressional authority.
Microbix Biosystems Inc., a biotechnology company focused on virology and biological technologies, and Therapure Biopharma Inc., an integrated biopharmaceutical company that develops, manufactures, purifies and packages therapeutic proteins, announced today the signing of a partnership agreement to manufacture and market water-based products to the pharmaceutical, biotechnology and other industries.
Intratumor morphological heterogeneity (diversity) of breast cancer is not related to chromosome aberrations. This conclusion was made based on the study of one case with aggressive variant of breast cancer - invasive micropapillary carcinoma by researchers from Tomsk State University, Tomsk Cancer Research Institute, and Institute of Medical Genetics.
The authors of a head-to-head study say that surgery should be considered as a first-line option for women with stress urinary incontinence, ahead of physiotherapy.
› Verified 5 days ago
| Entity Name | Arkansas Emergency Staffing Solutions Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275774630 PECOS PAC ID: 3274681341 Enrollment ID: O20090501000014 |
News Archive
The Clinical and Translational Science Award (CTSA) hub partnership between Virginia Tech, the University of Virginia, Carilion Clinic, and Inova Health System has awarded $200,000 in funding to five research projects through the Pilot Translational and Clinical Studies Program. Multi-institutional teams of scientists, physicians, and engineers will study Parkinson's disease, celiac disease, pediatric heart transplant, pediatric telemedicine, and epilepsy.
From the left, fears persist that this independent payment advisory board will make the Medicare program a cost-control scapegoat. On the right, opponents say the panel will lead to health care rationing and usurp congressional authority.
Microbix Biosystems Inc., a biotechnology company focused on virology and biological technologies, and Therapure Biopharma Inc., an integrated biopharmaceutical company that develops, manufactures, purifies and packages therapeutic proteins, announced today the signing of a partnership agreement to manufacture and market water-based products to the pharmaceutical, biotechnology and other industries.
Intratumor morphological heterogeneity (diversity) of breast cancer is not related to chromosome aberrations. This conclusion was made based on the study of one case with aggressive variant of breast cancer - invasive micropapillary carcinoma by researchers from Tomsk State University, Tomsk Cancer Research Institute, and Institute of Medical Genetics.
The authors of a head-to-head study say that surgery should be considered as a first-line option for women with stress urinary incontinence, ahead of physiotherapy.
› Verified 5 days ago
| Entity Name | Emergency Staffing Solutions Region Iii |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689967895 PECOS PAC ID: 3375721707 Enrollment ID: O20110706000473 |
News Archive
The Clinical and Translational Science Award (CTSA) hub partnership between Virginia Tech, the University of Virginia, Carilion Clinic, and Inova Health System has awarded $200,000 in funding to five research projects through the Pilot Translational and Clinical Studies Program. Multi-institutional teams of scientists, physicians, and engineers will study Parkinson's disease, celiac disease, pediatric heart transplant, pediatric telemedicine, and epilepsy.
From the left, fears persist that this independent payment advisory board will make the Medicare program a cost-control scapegoat. On the right, opponents say the panel will lead to health care rationing and usurp congressional authority.
Microbix Biosystems Inc., a biotechnology company focused on virology and biological technologies, and Therapure Biopharma Inc., an integrated biopharmaceutical company that develops, manufactures, purifies and packages therapeutic proteins, announced today the signing of a partnership agreement to manufacture and market water-based products to the pharmaceutical, biotechnology and other industries.
Intratumor morphological heterogeneity (diversity) of breast cancer is not related to chromosome aberrations. This conclusion was made based on the study of one case with aggressive variant of breast cancer - invasive micropapillary carcinoma by researchers from Tomsk State University, Tomsk Cancer Research Institute, and Institute of Medical Genetics.
The authors of a head-to-head study say that surgery should be considered as a first-line option for women with stress urinary incontinence, ahead of physiotherapy.
› Verified 5 days ago
| Entity Name | Ess Hospitalist Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881967305 PECOS PAC ID: 6103085295 Enrollment ID: O20120308000726 |
News Archive
The Clinical and Translational Science Award (CTSA) hub partnership between Virginia Tech, the University of Virginia, Carilion Clinic, and Inova Health System has awarded $200,000 in funding to five research projects through the Pilot Translational and Clinical Studies Program. Multi-institutional teams of scientists, physicians, and engineers will study Parkinson's disease, celiac disease, pediatric heart transplant, pediatric telemedicine, and epilepsy.
From the left, fears persist that this independent payment advisory board will make the Medicare program a cost-control scapegoat. On the right, opponents say the panel will lead to health care rationing and usurp congressional authority.
Microbix Biosystems Inc., a biotechnology company focused on virology and biological technologies, and Therapure Biopharma Inc., an integrated biopharmaceutical company that develops, manufactures, purifies and packages therapeutic proteins, announced today the signing of a partnership agreement to manufacture and market water-based products to the pharmaceutical, biotechnology and other industries.
Intratumor morphological heterogeneity (diversity) of breast cancer is not related to chromosome aberrations. This conclusion was made based on the study of one case with aggressive variant of breast cancer - invasive micropapillary carcinoma by researchers from Tomsk State University, Tomsk Cancer Research Institute, and Institute of Medical Genetics.
The authors of a head-to-head study say that surgery should be considered as a first-line option for women with stress urinary incontinence, ahead of physiotherapy.
› Verified 5 days ago
| Entity Name | Monticello Ess Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184010753 PECOS PAC ID: 4880914639 Enrollment ID: O20150519002625 |
News Archive
The Clinical and Translational Science Award (CTSA) hub partnership between Virginia Tech, the University of Virginia, Carilion Clinic, and Inova Health System has awarded $200,000 in funding to five research projects through the Pilot Translational and Clinical Studies Program. Multi-institutional teams of scientists, physicians, and engineers will study Parkinson's disease, celiac disease, pediatric heart transplant, pediatric telemedicine, and epilepsy.
From the left, fears persist that this independent payment advisory board will make the Medicare program a cost-control scapegoat. On the right, opponents say the panel will lead to health care rationing and usurp congressional authority.
Microbix Biosystems Inc., a biotechnology company focused on virology and biological technologies, and Therapure Biopharma Inc., an integrated biopharmaceutical company that develops, manufactures, purifies and packages therapeutic proteins, announced today the signing of a partnership agreement to manufacture and market water-based products to the pharmaceutical, biotechnology and other industries.
Intratumor morphological heterogeneity (diversity) of breast cancer is not related to chromosome aberrations. This conclusion was made based on the study of one case with aggressive variant of breast cancer - invasive micropapillary carcinoma by researchers from Tomsk State University, Tomsk Cancer Research Institute, and Institute of Medical Genetics.
The authors of a head-to-head study say that surgery should be considered as a first-line option for women with stress urinary incontinence, ahead of physiotherapy.
› Verified 5 days ago
| Entity Name | Hospital Care Consultants Of Fordyce Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316497464 PECOS PAC ID: 5395024475 Enrollment ID: O20161112000042 |
News Archive
The Clinical and Translational Science Award (CTSA) hub partnership between Virginia Tech, the University of Virginia, Carilion Clinic, and Inova Health System has awarded $200,000 in funding to five research projects through the Pilot Translational and Clinical Studies Program. Multi-institutional teams of scientists, physicians, and engineers will study Parkinson's disease, celiac disease, pediatric heart transplant, pediatric telemedicine, and epilepsy.
From the left, fears persist that this independent payment advisory board will make the Medicare program a cost-control scapegoat. On the right, opponents say the panel will lead to health care rationing and usurp congressional authority.
Microbix Biosystems Inc., a biotechnology company focused on virology and biological technologies, and Therapure Biopharma Inc., an integrated biopharmaceutical company that develops, manufactures, purifies and packages therapeutic proteins, announced today the signing of a partnership agreement to manufacture and market water-based products to the pharmaceutical, biotechnology and other industries.
Intratumor morphological heterogeneity (diversity) of breast cancer is not related to chromosome aberrations. This conclusion was made based on the study of one case with aggressive variant of breast cancer - invasive micropapillary carcinoma by researchers from Tomsk State University, Tomsk Cancer Research Institute, and Institute of Medical Genetics.
The authors of a head-to-head study say that surgery should be considered as a first-line option for women with stress urinary incontinence, ahead of physiotherapy.
› Verified 5 days ago
| Entity Name | Ess Of Fordyce Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821547977 PECOS PAC ID: 1254611601 Enrollment ID: O20161201001070 |
News Archive
The Clinical and Translational Science Award (CTSA) hub partnership between Virginia Tech, the University of Virginia, Carilion Clinic, and Inova Health System has awarded $200,000 in funding to five research projects through the Pilot Translational and Clinical Studies Program. Multi-institutional teams of scientists, physicians, and engineers will study Parkinson's disease, celiac disease, pediatric heart transplant, pediatric telemedicine, and epilepsy.
From the left, fears persist that this independent payment advisory board will make the Medicare program a cost-control scapegoat. On the right, opponents say the panel will lead to health care rationing and usurp congressional authority.
Microbix Biosystems Inc., a biotechnology company focused on virology and biological technologies, and Therapure Biopharma Inc., an integrated biopharmaceutical company that develops, manufactures, purifies and packages therapeutic proteins, announced today the signing of a partnership agreement to manufacture and market water-based products to the pharmaceutical, biotechnology and other industries.
Intratumor morphological heterogeneity (diversity) of breast cancer is not related to chromosome aberrations. This conclusion was made based on the study of one case with aggressive variant of breast cancer - invasive micropapillary carcinoma by researchers from Tomsk State University, Tomsk Cancer Research Institute, and Institute of Medical Genetics.
The authors of a head-to-head study say that surgery should be considered as a first-line option for women with stress urinary incontinence, ahead of physiotherapy.
› Verified 5 days ago
| Entity Name | Hcc Of Warren Hospitalist, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326641606 PECOS PAC ID: 5698189280 Enrollment ID: O20210121002187 |
News Archive
The Clinical and Translational Science Award (CTSA) hub partnership between Virginia Tech, the University of Virginia, Carilion Clinic, and Inova Health System has awarded $200,000 in funding to five research projects through the Pilot Translational and Clinical Studies Program. Multi-institutional teams of scientists, physicians, and engineers will study Parkinson's disease, celiac disease, pediatric heart transplant, pediatric telemedicine, and epilepsy.
From the left, fears persist that this independent payment advisory board will make the Medicare program a cost-control scapegoat. On the right, opponents say the panel will lead to health care rationing and usurp congressional authority.
Microbix Biosystems Inc., a biotechnology company focused on virology and biological technologies, and Therapure Biopharma Inc., an integrated biopharmaceutical company that develops, manufactures, purifies and packages therapeutic proteins, announced today the signing of a partnership agreement to manufacture and market water-based products to the pharmaceutical, biotechnology and other industries.
Intratumor morphological heterogeneity (diversity) of breast cancer is not related to chromosome aberrations. This conclusion was made based on the study of one case with aggressive variant of breast cancer - invasive micropapillary carcinoma by researchers from Tomsk State University, Tomsk Cancer Research Institute, and Institute of Medical Genetics.
The authors of a head-to-head study say that surgery should be considered as a first-line option for women with stress urinary incontinence, ahead of physiotherapy.
› Verified 5 days ago
| Entity Name | Hcc Of Warren Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952904237 PECOS PAC ID: 6406260371 Enrollment ID: O20210204001426 |
News Archive
The Clinical and Translational Science Award (CTSA) hub partnership between Virginia Tech, the University of Virginia, Carilion Clinic, and Inova Health System has awarded $200,000 in funding to five research projects through the Pilot Translational and Clinical Studies Program. Multi-institutional teams of scientists, physicians, and engineers will study Parkinson's disease, celiac disease, pediatric heart transplant, pediatric telemedicine, and epilepsy.
From the left, fears persist that this independent payment advisory board will make the Medicare program a cost-control scapegoat. On the right, opponents say the panel will lead to health care rationing and usurp congressional authority.
Microbix Biosystems Inc., a biotechnology company focused on virology and biological technologies, and Therapure Biopharma Inc., an integrated biopharmaceutical company that develops, manufactures, purifies and packages therapeutic proteins, announced today the signing of a partnership agreement to manufacture and market water-based products to the pharmaceutical, biotechnology and other industries.
Intratumor morphological heterogeneity (diversity) of breast cancer is not related to chromosome aberrations. This conclusion was made based on the study of one case with aggressive variant of breast cancer - invasive micropapillary carcinoma by researchers from Tomsk State University, Tomsk Cancer Research Institute, and Institute of Medical Genetics.
The authors of a head-to-head study say that surgery should be considered as a first-line option for women with stress urinary incontinence, ahead of physiotherapy.
› Verified 5 days ago
| Entity Name | Hcc Of Magnolia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831865872 PECOS PAC ID: 3779980750 Enrollment ID: O20210917000064 |
News Archive
The Clinical and Translational Science Award (CTSA) hub partnership between Virginia Tech, the University of Virginia, Carilion Clinic, and Inova Health System has awarded $200,000 in funding to five research projects through the Pilot Translational and Clinical Studies Program. Multi-institutional teams of scientists, physicians, and engineers will study Parkinson's disease, celiac disease, pediatric heart transplant, pediatric telemedicine, and epilepsy.
From the left, fears persist that this independent payment advisory board will make the Medicare program a cost-control scapegoat. On the right, opponents say the panel will lead to health care rationing and usurp congressional authority.
Microbix Biosystems Inc., a biotechnology company focused on virology and biological technologies, and Therapure Biopharma Inc., an integrated biopharmaceutical company that develops, manufactures, purifies and packages therapeutic proteins, announced today the signing of a partnership agreement to manufacture and market water-based products to the pharmaceutical, biotechnology and other industries.
Intratumor morphological heterogeneity (diversity) of breast cancer is not related to chromosome aberrations. This conclusion was made based on the study of one case with aggressive variant of breast cancer - invasive micropapillary carcinoma by researchers from Tomsk State University, Tomsk Cancer Research Institute, and Institute of Medical Genetics.
The authors of a head-to-head study say that surgery should be considered as a first-line option for women with stress urinary incontinence, ahead of physiotherapy.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amber Jackson, DO 3417 U Of A Way, Texarkana, AR 71854-1419 Ph: (870) 779-6000 | Dr Amber Jackson, DO 300 E 6th St, Texarkana, AR 71854-5207 Ph: (870) 779-6000 |
News Archive
The Clinical and Translational Science Award (CTSA) hub partnership between Virginia Tech, the University of Virginia, Carilion Clinic, and Inova Health System has awarded $200,000 in funding to five research projects through the Pilot Translational and Clinical Studies Program. Multi-institutional teams of scientists, physicians, and engineers will study Parkinson's disease, celiac disease, pediatric heart transplant, pediatric telemedicine, and epilepsy.
From the left, fears persist that this independent payment advisory board will make the Medicare program a cost-control scapegoat. On the right, opponents say the panel will lead to health care rationing and usurp congressional authority.
Microbix Biosystems Inc., a biotechnology company focused on virology and biological technologies, and Therapure Biopharma Inc., an integrated biopharmaceutical company that develops, manufactures, purifies and packages therapeutic proteins, announced today the signing of a partnership agreement to manufacture and market water-based products to the pharmaceutical, biotechnology and other industries.
Intratumor morphological heterogeneity (diversity) of breast cancer is not related to chromosome aberrations. This conclusion was made based on the study of one case with aggressive variant of breast cancer - invasive micropapillary carcinoma by researchers from Tomsk State University, Tomsk Cancer Research Institute, and Institute of Medical Genetics.
The authors of a head-to-head study say that surgery should be considered as a first-line option for women with stress urinary incontinence, ahead of physiotherapy.
› Verified 5 days ago
Dr. Kyle I Diaz, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 E 6th St, Texarkana, AR 71854 Phone: 870-779-6000 Fax: 870-779-6093 | |
Dr. Sangeeth Jonathan Samuel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2109 White Oak Ln, Texarkana, AR 71854 Phone: 501-664-6809 | |
Dr. Matthew Wayne Nix, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 E 6th St, Texarkana, AR 71854 Phone: 870-779-6000 Fax: 870-779-6119 | |
Shanna Leigh Spence, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 300 E 6th St, Texarkana, AR 71854 Phone: 870-779-6004 Fax: 870-779-6100 | |
Kenneth George Ross, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3417 U Of A Way, Texarkana, AR 71854 Phone: 870-779-6000 Fax: 870-779-6055 | |
Daniel Morgan Tucker, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 600 E 6th St, Texarkana, AR 71854 Phone: 870-779-6000 Fax: 870-779-6093 | |
Alissa Waddell, FNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 401 East St, Texarkana, AR 71854 Phone: 870-216-1223 |